A Study of Deafness in Term Infants with Birth Asphyxia by Otoacoustic Emissions and Brainstem Evoked Response Audiometry Tests
International Journal of Current Pharmaceutical Review and Research · 13.05.2026 · 18 (05)
DOI: 10.25258/ijcpr.18.5.13 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 13.05.2026. Verfasst von Subodh Kumar und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Birth asphyxia is the leading cause of neonatal morbidity and mortality and results in substantial neurological sequelae. Hypoxic-ischemic damage can involve both peripheral and central auditory pathways, which may make these infants at high risk for hearing loss. The early detection of hearing loss is crucial in preventing resultant speech, language, and cognitive developmental delays.
Methods
This was a prospective observational study done in the Neonatal Intensive Care Unit (NICU) of a tertiary care hospital for the duration of 1 year from January 2025 to January 2026. One hundred fifty full-term neonates (≥37 weeks' gestation) who were diagnosed with birth asphyxia were recruited. All neonates had at least one Otoacoustic emissions (OAE) screen before either discharge or 1 month of age. Patients with a “Refer” response on the screening test had been submitted for confirmatory Brainstem evoked response audiometry (BERA), testing to evaluate auditory pathway integrity and measurement of hearing thresholds. The severity of asphyxia was graded as per Sarnat stage of hypoxic-ischemic encephalopathy. Analysis was performed in SPSS, and the relationship of severity to hearing loss was evaluated by the chi-square test.
Results
The referral rate of the OAE screening was 20%. BERA confirmed hearing loss was found in 12 (rate 8%). The prevalence of hearing loss is designed with the severity of asphyxia, being highest in infants with severe hypoxic-ischemic encephalopathy. There was a significant relationship between the severity of asphyxia and hearing loss (p < 0.05).
Conclusion
Birth asphyxia is an important risk factor of neonatal hearing impairment, in particular for severe cases. Single-step screening for bilaterally impaired hearing with OAE and confirmatory BERA helps in early detection and definitive diagnosis. Regular hearing screening for asphyxiated neonates is necessary in order to enable prompt intervention and to optimize developmental outcome.
Zitieren
APA
Kumar, S., & Kumar, A. (2026). A Study of Deafness in Term Infants with Birth Asphyxia by Otoacoustic Emissions and Brainstem Evoked Response Audiometry Tests. International Journal of Current Pharmaceutical Review and Research, 18(05). https://doi.org/10.25258/ijcpr.18.5.13
Vancouver
Kumar S, Kumar A. A Study of Deafness in Term Infants with Birth Asphyxia by Otoacoustic Emissions and Brainstem Evoked Response Audiometry Tests. International Journal of Current Pharmaceutical Review and Research. 2026;18(05). doi:10.25258/ijcpr.18.5.13
BibTeX
@article{Kumar2026,
author = {Kumar, Subodh and Kumar, Abhinav},
title = {A Study of Deafness in Term Infants with Birth Asphyxia by Otoacoustic Emissions and Brainstem Evoked Response Audiometry Tests},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {05},
doi = {10.25258/ijcpr.18.5.13}
}
EUVIMED